GSTO1 aggravates EGFR-TKIs resistance and tumor metastasis via deglutathionylation of NPM1 in lung adenocarcinoma. Shen NX, Luo MY, Gu WM, Gong M, et al. Oncogene 2024;43:2504-2516.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Shen NX, Luo MY, Gu WM, Gong M, et al. GSTO1 aggravates EGFR-TKIs resistance and tumor metastasis via deglutathionylation of NPM1 in lung adenocarcinoma. Oncogene 2024;43:2504-2516.
PMID: 38969770